Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Pharmacol.

Sec. Ethnopharmacology

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1687681

This article is part of the Research TopicArtificial Intelligence in Traditional Medicine Research and ApplicationView all 16 articles

Application and Research Progress on Artificial Intelligence in the Quality of Traditional Chinese Medicine

Provisionally accepted
Mei Yu  LiMei Yu LiJunqing  ZhuJunqing ZhuXiaonan  LiuXiaonan LiuMengyue  wuMengyue wuKun  DongKun DongXiaoyan  LiXiaoyan LiPeng  GaoPeng Gao*Zhihui  JiangZhihui Jiang*
  • Shandong University of Traditional Chinese Medicine, Jinan, China

The final, formatted version of the article will be published soon.

The clinical safety and therapeutic performance of Traditional Chinese Medicine (TCM) are closely tied to its quality. However, with the rapid expansion of the TCM industry, conventional quality control approaches based on empirical observations and single-metabolite quantification have become increasingly inadequate for addressing the complex and variable requirements of quality assessment. In recent years, artificial intelligence (AI)—with strong capabilities in data processing and pattern recognition—has emerged as a promising tool for establishing predictive models to efficiently handle heterogeneous, multi-source datasets (such as spectra, chromatograms, images, and textual information). This enables intelligent prediction of quality indicators and anomaly detection, and offering novel strategies for modernizing TCM quality control. This review provides a comprehensive synthesis of commonly applied machine learning and deep learning algorithms, systematically outlining recent advances in AI-enabled sensing applications such as image recognition, odor analysis, authenticity verification, origin tracing, quality grading, and storage-age determination. It further emphasizes the integration of AI with multi-omics and bioinformatics approaches for efficacy-oriented evaluation and safety assessment, including identification of Q-markers, elucidation of pharmacodynamic mechanisms, and predictive modeling of both endogenous and exogenous toxic metabolites. It also identifies key challenges and technical bottlenecks, and outlines priorities for building scalable, regulation-aware, data-driven quality-control systems that support the sustainable, high-quality development of the TCM industry.

Keywords: artificial intelligence, bioinformatics, Quality control, Traditional Chinese Medicine, Mechanism, multi-omics technologies

Received: 19 Aug 2025; Accepted: 09 Oct 2025.

Copyright: © 2025 Li, Zhu, Liu, wu, Dong, Li, Gao and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Peng Gao, 1915438423@qq.com
Zhihui Jiang, 60230107@sdutcm.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.